TGF-beta/Smad signaling in the injured liver
- PMID: 16397841
- DOI: 10.1055/s-2005-858989
TGF-beta/Smad signaling in the injured liver
Abstract
TGF-beta, acting both directly and indirectly, represents a central mediator of fibrogenic remodeling processes in the liver. Besides hepatic stellate cells (HSCs), which are induced by TGF-beta to transdifferentiate to myofibroblasts and to produce extracellular matrix, hepatocytes are also strongly responsive for this cytokine, which induces apoptosis during fibrogenesis and provides growth control in regeneration processes. Based on this, TGF-beta-mediated hepatic responses to injury are the result of a complex interplay between the different liver cell types. In this review we summarize the knowledge about TGF-beta signal transduction in HSCs with special impact on Smad pathways. We further describe a molecular cross-talk between profibrogenic TGF-beta and antifibrogenic IFN-gamma signaling in liver cells. Finally, we introduce hepatocyte plasticity and epithelial-to-mesenchymal transition in the liver, which is well established in tumorigenesis, as a potential feature of fibrogenesis and highlight possible action points of TGF-beta in these contexts.
Similar articles
-
IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads.J Hepatol. 2007 Feb;46(2):295-303. doi: 10.1016/j.jhep.2006.09.014. Epub 2006 Nov 3. J Hepatol. 2007. PMID: 17125875
-
Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.Gastroenterology. 2008 Aug;135(2):642-59. doi: 10.1053/j.gastro.2008.04.038. Epub 2008 May 15. Gastroenterology. 2008. PMID: 18602923
-
Transforming growth factor-beta and hepatocyte transdifferentiation in liver fibrogenesis.J Gastroenterol Hepatol. 2008 Mar;23 Suppl 1:S122-7. doi: 10.1111/j.1440-1746.2007.05297.x. J Gastroenterol Hepatol. 2008. PMID: 18336655
-
TGF-beta signaling: a tale of two responses.J Cell Biochem. 2007 Oct 15;102(3):593-608. doi: 10.1002/jcb.21501. J Cell Biochem. 2007. PMID: 17729308 Review.
-
[Mechanism of transforming growth factor beta/Smad signaling and the relationship between its transduction and liver fibrosis].Zhonghua Gan Zang Bing Za Zhi. 2005 Jun;13(6):476-8. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 15975296 Review. Chinese. No abstract available.
Cited by
-
Kaempferol attenuates liver fibrosis by inhibiting activin receptor-like kinase 5.J Cell Mol Med. 2019 Sep;23(9):6403-6410. doi: 10.1111/jcmm.14528. Epub 2019 Jul 5. J Cell Mol Med. 2019. PMID: 31273920 Free PMC article.
-
Targeting Hepatic Stellate Cells for the Treatment of Liver Fibrosis by Natural Products: Is It the Dawning of a New Era?Front Pharmacol. 2020 Apr 30;11:548. doi: 10.3389/fphar.2020.00548. eCollection 2020. Front Pharmacol. 2020. PMID: 32425789 Free PMC article. Review.
-
Current experimental perspectives on the clinical progression of alcoholic liver disease.Alcohol Clin Exp Res. 2009 Oct;33(10):1647-55. doi: 10.1111/j.1530-0277.2009.01015.x. Epub 2009 Jul 23. Alcohol Clin Exp Res. 2009. PMID: 19645734 Free PMC article. Review.
-
The Differential and Dynamic Progression of Hepatic Inflammation and Immune Responses During Liver Fibrosis Induced by Schistosoma japonicum or Carbon Tetrachloride in Mice.Front Immunol. 2020 Oct 7;11:570524. doi: 10.3389/fimmu.2020.570524. eCollection 2020. Front Immunol. 2020. PMID: 33117360 Free PMC article.
-
Advances in antifibrotic therapy.Expert Rev Gastroenterol Hepatol. 2008 Dec;2(6):803-16. doi: 10.1586/17474124.2.6.803. Expert Rev Gastroenterol Hepatol. 2008. PMID: 19090740 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical